DOROTHY PORTER: Open Payments
NPI 1871849133 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 59 payments from 16 companies in 2025. Trend: 2023 $1,068 · 2024 $979 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $395 |
| Madrigal Pharmaceuticals | 6 | $156 |
| Aimmune Therapeutics, Inc. | 5 | $106 |
| GENZYME CORPORATION | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Ipsen Biopharmaceuticals, Inc | 3 | $84 |
| QOL Medical, LLC | 2 | $61 |
| Gilead Sciences, Inc. | 2 | $59 |
| Lilly USA, LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $48 |
Products named: REZDIFFRA, DUPIXENT, SKYRIZI, LINZESS, ZENPEP, RINVOQ, XIFAXAN, IQIRVO.
Industry payments across FL — which companies pay providers there.
